Grant Pickering - Jun 21, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Jun 21, 2022
Transactions value $
-$215,639
Form type
4
Date filed
6/23/2022, 05:48 PM
Previous filing
May 27, 2022
Next filing
Jun 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$115K -5.45K -0.77% $21.05 700K Jun 21, 2022 Direct F1, F2, F3
transaction PCVX Common Stock Sale -$26.5K -1.26K -0.18% $21.01 699K Jun 22, 2022 Direct F1, F4
transaction PCVX Common Stock Sale -$74.4K -3.54K -0.51% $21.01 695K Jun 23, 2022 Direct F1, F5
holding PCVX Common Stock 356K Jun 21, 2022 By Children's Trusts
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 1,562 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.
F4 The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.065. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.